HARROW, INC. — Director's Dealing 2009

Jun 23, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSDEL PHARMACEUTICALS INC (TDLP.OB)
CIK: 0001360214
Period of Report: 2009-06-18

Reporting Person: Singh Juliet (Director, CEO, Director and President, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-06-18	Employee Stock Option (right to buy)	$1.60	A	200000	Acquired	2019-06-18	Common Stock (200000)	Direct

Footnotes

F1: The options vest one-twelfth per quarter commencing on the first full quarter after the initial grant date of June 18, 2009.